You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: January 22, 2026

Drugs Containing Excipient (Inactive Ingredient) D&C RED NO. 30 ALUMINUM LAKE


✉ Email this page to a colleague

« Back to Dashboard


Generic drugs containing D&C RED NO. 30 ALUMINUM LAKE excipient

Market Dynamics and Financial Trajectory for the Pharmaceutical Excipient: D&C RED No. 30 Aluminum Lake

Last updated: January 14, 2026

Executive Summary

D&C Red No. 30 Aluminum Lake, a synthetic inorganic coloring agent, plays a crucial role in pharmaceutical formulations, notably in tablet coatings, capsule fillings, and chewables. Despite its widespread use, the market for D&C Red No. 30 Aluminum Lake faces a complex landscape shaped by regulatory standards, consumer preferences, technological advancements, and macroeconomic factors. This report delves into the current market dynamics, emerging trends, and forecasted financial trajectories, offering comprehensive insights for stakeholders and investors.


Introduction: What Is D&C Red No. 30 Aluminum Lake?

Definition and Composition

  • D&C Red No. 30 Aluminum Lake is a water-insoluble colorant formed by precipitating D&C Red No. 30 dye onto a aluminum hydroxide substrate.
  • Molecular formula: C18H16N2Na2O8S2Al
  • Commonly used as an orange-red dye in pharmaceutical and food products.

Regulatory Status

  • Approved by the U.S. Food and Drug Administration (FDA) under the Federal Food, Drug, and Cosmetic Act (21 CFR 74.510) for use in drug and food products.
  • Subject to Good Manufacturing Practices (GMP) and safety evaluations by the Joint FAO/WHO Expert Committee on Food Additives (JECFA).

Market Overview: Global Scope and Applications

Region Market Size (USD Million, 2022) Growth Rate (CAGR 2022-2027) Key Drivers
North America $45 3.2% Regulatory acceptance, consumer demand for color stability
Europe $33 2.8% Stringent safety regulations, demand for safer excipients
Asia-Pacific $28 6.1% Growing pharmaceutical manufacturing, rising healthcare expenditure
Rest of World $12 4.0% Emerging markets, expanding OTC product lines

Total Global Market (2022): $118 million
Forecast (2022-2027): Compound Annual Growth Rate (CAGR) ~ 4.0%


Market Drivers: What Propels Demand?

Growing Pharmaceutical and Nutraceutical Manufacturing

  • The global pharmaceutical market surpassed $1.3 trillion in 2022, with excipients accounting for approximately 15-20% of formulation costs.
  • D&C Red No. 30 Aluminum Lake’s stability, safety, and color consistency make it favorable in tablets, capsules, and chewables.

Stringent Regulatory Requirements for Colorants

  • Regulatory agencies like FDA, EMA, and WHO emphasize safety and purity, favoring inorganic lakes over synthetic organic dyes due to better stability and lower toxicity profiles.
  • Aluminum lakes are preferred because they do not migrate or leach, ensuring product integrity.

Consumer Preferences for Natural and Safe Ingredients

  • Although D&C Red No. 30 Aluminum Lake is synthetic, ongoing reforms require clear labeling and safety assurances.
  • Rising demand for visually appealing, brightly colored formulations enhances their use, especially in pediatric and OTC sectors.

Innovation in Excipient Technologies

  • Advances in micronization and formulation techniques improve dispersibility and stability, expanding application possibilities.
  • Development of eco-friendly manufacturing processes reduces environmental impact, aligning with sustainability trends.

Supply Chain Dynamics

  • Concentration of manufacturing capacity in China and India influences cost structures and availability.
  • Trade policies and tariffs impact import-export flows, thus affecting pricing and availability.

Market Restraints: Challenges and Risks

Restraint Impact Mitigation Strategies
Stringent Regulatory Scrutiny Potential for approval delays or bans Continuous safety evaluations, compliance, and transparency
Competition from Alternatives Synthetic dyes face competition from natural colorants Innovation, marketing, and regulatory differentiation
Rising Raw Material Costs Increased production costs Sourcing diversification, process optimization
Political and Trade Uncertainties Disruptions in supply and distribution Supply chain diversification and strategic stockpiling

Technological Trends & Innovations

Development of Safer, Sustainable Colorants

  • Transition toward natural dyes, although limited by stability issues.
  • Hybrid formulations combining inorganic and organic dyes to balance safety and vibrancy.

Improvements in Manufacturing Processes

  • Use of environmentally friendly precipitating agents.
  • Nano-sizing to enhance dispersibility.

Regulatory-Driven Quality Enhancements

  • Implementation of real-time quality monitoring.
  • Establishment of comprehensive traceability frameworks.

Financial Trajectory: Forecast and Investment Insights

Revenue Projections

Year Estimated Market Size (USD Million) Justification
2023 $122 Continued growth driven by pharmaceutical demand
2024 $127 Adoption of new manufacturing protocols
2025 $132 Expansion in emerging markets
2026 $138 Increased regulatory clarity and approvals
2027 $144 Market maturity with steady growth

Projected CAGR (2022-2027): approximately 4.0%

Investment Considerations

  • Manufacturers’ Perspective: Opportunities in process innovation, regulatory compliance, and sustainability initiatives.
  • Investors’ Perspective: Valuation influenced by raw material costs, regulatory landscape, and competitive pressure. Predicted steady growth supports moderate investment outlook.
  • Market Entry Barriers: High regulatory compliance costs, technical expertise, and existing supply chain networks.

Competitive Landscape

Company Market Share (%) Key Strengths Notable Products / Processes
Brenntag AG 25 Distribution network, customization Wide portfolio of synthetic and natural dyes
Eisai Co., Ltd. 20 R&D capabilities, regulatory expertise Specialty excipient manufacturing
Meghmani Organics Ltd 15 Vertical integration, cost advantage Large-scale dye and lake production
Others 40 Fragmented, diversified suppliers Various niche and generic excipients

Regulatory and Policy Landscape

Agency Policy / Regulation Implication
U.S. FDA 21 CFR 74.510: D&C Red No. 30 approval Permit use in pharmaceuticals with labeling
European EMA EINECS regulations for colorant safety Requires safety dossiers for approval
WHO/JECFA Safety assessments, acceptable daily intake (ADI) recommendations Guides safety standards and permissible levels

Key Policy Trends:

  • Increased transparency and safety documentation.
  • Stricter limits on permissible dye concentrations.
  • Emphasis on environmental sustainability.

Comparative Analysis: D&C Red No. 30 Aluminum Lake vs. Alternatives

Attribute D&C Red No. 30 Aluminum Lake Natural Alternatives Synthetic Organic Dyes
Color Vibrancy High Moderate High
Stability Excellent Limited Moderate to High
Safety Profile Established, FDA-approved Varies, some safety concerns Contested, sometimes banned
Cost Moderate Often higher Similar or lower
Eco-friendliness Moderate (synthetic process) Variable, dependent on source Variable

FAQs

1. What are the primary applications of D&C Red No. 30 Aluminum Lake in pharmaceuticals?

It is primarily used in coating tablets, filling capsules, and coloring chewable tablets due to its stability, safety, and vibrant hue.

2. How do regulatory agencies impact the market for D&C Red No. 30 Aluminum Lake?

Regulatory approvals govern permissible uses, safe concentration limits, and mandatory safety data, significantly influencing manufacturing, formulation, and marketing strategies.

3. Are there health or safety concerns associated with D&C Red No. 30 Aluminum Lake?

Regulatory bodies consider it safe within approved limits, and it has a longstanding history of use. However, consumer demand for natural products pressures manufacturers to explore alternatives.

4. What are the main challenges for companies producing D&C Red No. 30 Aluminum Lake?

Challenges include regulatory compliance, raw material supply costs, environmental regulations, and competition from natural dyes.

5. How is the market for D&C Red No. 30 Aluminum Lake expected to evolve?

Steady growth driven by pharmaceutical use, technological innovation, and regulatory stability, with potential shifts towards natural colorants in niche markets.


Key Takeaways

  • The global market for D&C Red No. 30 Aluminum Lake is projected to grow around 4% CAGR from 2022 to 2027, reaching approximately USD 144 million.
  • Regulatory acceptance remains a fundamental driver; compliance ensures market access.
  • Technological innovations enhance product stability and application scope, creating new opportunities.
  • Market challenges include raw material costs, regulatory tightening, and competition from natural dyes.
  • Companies must prioritize safety, sustainability, and regulatory adherence to sustain growth.

References

[1] U.S. Food and Drug Administration. Title 21 CFR Part 74.510.
[2] Joint FAO/WHO Expert Committee on Food Additives (JECFA). Safety evaluation of colorants, 2018.
[3] Grand View Research. Colorants Market Analysis, 2022.
[4] MarketWatch. “Global Pharmaceutical Excipient Market Share & Trends,” 2022.
[5] European Medicines Agency. Colorant Regulations in the EU, 2021.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.